Chemed forecasts 5.5%-6.5% VITAS revenue growth and signals 55% of 2026 earnings to be back-half weighted amid transition initiatives
Source: SeekingAlpha
2026-02-26 15:09:36 ET
More on Chemed
- Chemed Corporation (CHE) Q4 2025 Earnings Call Transcript
- Chemed cut to Neutral at BofA after Q4 miss
- Chemed Non-GAAP EPS of $6.42 misses by $0.61, revenue of $639.3M misses by $19.79M
- Seeking Alpha’s Quant Rating on Chemed
- Historical earnings data for Chemed
Read the full article on Seeking Alpha
For further details see:
Chemed forecasts 5.5%–6.5% VITAS revenue growth and signals 55% of 2026 earnings to be back-half weighted amid transition initiatives
Chemed Corp
NASDAQ: CHE
CHE Trading
-0.15% G/L:
$403.88 Last:
90,172 Volume:
$398.91 Open:
CHE Latest News
February 16, 2026 12:35:33 pm
Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake
CHE Stock Data
$6,431,677,666
13,693,944
1.88%
225
N/A
Healthcare Providers & Services
Healthcare
US
Cincinnati
